Literature DB >> 18209856

Screening and diagnosis of Cushing's syndrome.

Margaret de Castro1, Ayrton C Moreira.   

Abstract

Cushing's syndrome (CS) results from sustained pathologic hypercortisolism. The clinical features are variable and the most specific features for CS include abnormal fat distribution, particularly in the supraclavicular and temporal fossae, proximal muscle weakness, wide purple striae, and decreased linear growth with continued weight gain in a child. Clinical presentation of CS can be florid and in this case the diagnosis is usually straightforward. However, the diagnosis can be difficult particularly in states of mild or cyclical or periodical hypercortisolism. Several tests based on the understanding of the physiologic characteristics of the hypothalamic-pituitary-adrenal axis have been used extensively to confirm the diagnosis of Cushing's syndrome, but none has proven fully capable of distinguishing all cases of CS from normal and/or pseudo-Cushing individuals. Three first-line diagnostic tests are currently used to screen for CS: measurement of free cortisol in 24-hour urine (UFC), cortisol suppressibility by low doses of dexamethasone (DST), and assessment of cortisol circadian rhythm using late-night serum and/or salivary cortisol. This paper discusses the effectiveness regarding best cut-off values, the sensitivity and the specificity of these tests to screen for CS. Late-night salivary cortisol appears to be the most useful screening test. UFC and DST should be performed to provide further confirmation of the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18209856     DOI: 10.1590/s0004-27302007000800004

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  6 in total

1.  Possible ACTH-independent, cortisol-secreting and DHEA-secreting metastatic hepatocellular carcinoma causing Cushing's syndrome.

Authors:  Alan Sacerdote; Taiga Inoue; Nithin Thomas; Gul Bahtiyar
Journal:  BMJ Case Rep       Date:  2015-12-23

2.  Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing's disease.

Authors:  Ludmilla Malveira Lima Lopes; Rossana Pulcineli Vieira Francisco; Marco Aurélio Knippel Galletta; Marcello Delano Bronstein
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

3.  Cushing's syndrome with uncontrolled hypertension, occasional hypokalemia, and two pregnancies.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-07-01       Impact factor: 3.738

Review 4.  Cushing's syndrome: epidemiology and developments in disease management.

Authors:  Susmeeta T Sharma; Lynnette K Nieman; Richard A Feelders
Journal:  Clin Epidemiol       Date:  2015-04-17       Impact factor: 4.790

5.  Beyond the metabolic syndrome: Visceral and marrow adipose tissues impair bone quantity and quality in Cushing's disease.

Authors:  Sérgio Luchini Batista; Iana Mizumukai de Araújo; Adriana Lelis Carvalho; Maria Augusta V S D Alencar; Andressa K Nahas; Jorge Elias; Marcello H Nogueira-Barbosa; Carlos E G Salmon; Paula C L Elias; Ayrton C Moreira; Margaret Castro; Francisco J A de Paula
Journal:  PLoS One       Date:  2019-10-15       Impact factor: 3.240

6.  Evaluation of the level of cortisol, capillary blood glucose, and blood pressure in response to anxiety of patients rehabilitated with complete dentures.

Authors:  Marcelo Coelho Goiato; Emily Vivianne Freitas da Silva; Nádia Biage Cândido; Adhara Smith Nóbrega; Rodrigo Antonio de Medeiros; Doris Hissako Sumida; Fernando Yamamoto Chiba; Daniela Micheline Dos Santos
Journal:  BMC Oral Health       Date:  2019-05-03       Impact factor: 2.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.